中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2015年
14期
2645-2648
,共4页
阿娜尔古丽·阿布都热合曼%吾甫尔·吾拉木%丁剑冰%迪丽努尔·阿西木
阿娜爾古麗·阿佈都熱閤曼%吾甫爾·吾拉木%丁劍冰%迪麗努爾·阿西木
아나이고려·아포도열합만%오보이·오랍목%정검빙%적려노이·아서목
肿瘤分期%直肠肿瘤%肿瘤辅助疗法
腫瘤分期%直腸腫瘤%腫瘤輔助療法
종류분기%직장종류%종류보조요법
Neoplasm staging%Rectal neoplasms%Neoadjuvant therapy
目的:探讨病理分期对新辅助治疗直肠癌患者预后的影响。方法回顾性分析2004年1月至2011年12月期间我院接受新辅助治疗+根治性手术治疗的152例中晚期直肠癌患者的临床资料和术后生存状况。采用 Kaplan-Meier 法计算各亚组3年无病生存率(DFS),并用 Log-rank检验进行比较。采用单因素和多因素 Cox 比例风险回归模型进行预后分析。结果全部患者的3年DFS 为84.3%。T、N 分期、淋巴结转移率、局部浸润因素、术前 CEA、CA19-9水平的各亚组之间的3年 DFS 比较,差异有统计学意义(P<0.05)。N 分期、淋巴结转移率、局部浸润因素和术前 CEA水平是影响直肠癌患者预后的独立影响因素(P<0.05)。结论直肠癌新辅助治疗后仍然推荐进行手术治疗,术后病理分期与患者的预后密切相关,其中 N 分期、淋巴结转移率、局部浸润因素是其独立影响因素。
目的:探討病理分期對新輔助治療直腸癌患者預後的影響。方法迴顧性分析2004年1月至2011年12月期間我院接受新輔助治療+根治性手術治療的152例中晚期直腸癌患者的臨床資料和術後生存狀況。採用 Kaplan-Meier 法計算各亞組3年無病生存率(DFS),併用 Log-rank檢驗進行比較。採用單因素和多因素 Cox 比例風險迴歸模型進行預後分析。結果全部患者的3年DFS 為84.3%。T、N 分期、淋巴結轉移率、跼部浸潤因素、術前 CEA、CA19-9水平的各亞組之間的3年 DFS 比較,差異有統計學意義(P<0.05)。N 分期、淋巴結轉移率、跼部浸潤因素和術前 CEA水平是影響直腸癌患者預後的獨立影響因素(P<0.05)。結論直腸癌新輔助治療後仍然推薦進行手術治療,術後病理分期與患者的預後密切相關,其中 N 分期、淋巴結轉移率、跼部浸潤因素是其獨立影響因素。
목적:탐토병리분기대신보조치료직장암환자예후적영향。방법회고성분석2004년1월지2011년12월기간아원접수신보조치료+근치성수술치료적152례중만기직장암환자적림상자료화술후생존상황。채용 Kaplan-Meier 법계산각아조3년무병생존솔(DFS),병용 Log-rank검험진행비교。채용단인소화다인소 Cox 비례풍험회귀모형진행예후분석。결과전부환자적3년DFS 위84.3%。T、N 분기、림파결전이솔、국부침윤인소、술전 CEA、CA19-9수평적각아조지간적3년 DFS 비교,차이유통계학의의(P<0.05)。N 분기、림파결전이솔、국부침윤인소화술전 CEA수평시영향직장암환자예후적독립영향인소(P<0.05)。결론직장암신보조치료후잉연추천진행수술치료,술후병리분기여환자적예후밀절상관,기중 N 분기、림파결전이솔、국부침윤인소시기독립영향인소。
Objective To investigate the effect of pathological staging of neoadjuvant therapy for prognosis of patients with rectal cancer. Methods Clinical data and postoperative survival status of 152 patients with advanced rectal cancer who received neoadjuvant therapy + radical surgical treatment in our hospital from January 2004 to December 2011 were retrospectively analyzed. Kaplan-Meier method was used to calculate 3-year disease-free survival (DFS) of each sub-group, and Log-rank test was performed to compare. Univariate and multivariate Cox proportional hazard regression model were used to prognosis analysis. Results All patients’ 3-year DFS was 84.3%. There were significant differences in 3-year DFS among sub-groups of T, N stage, lymph node metastasis rate, local infiltration factor, preoperative CEA, CA19-9 levels (P<0.05). N stage, lymph node metastasis rate, local infiltration factor and preoperative CEA level were independent prognostic factors of patients with rectal cancer. Conclusions Operation is still recommend for patients with rectal cancer after neoadjuvant therapy. Postoperative pathological staging is closely related with prognosis, and N stage, lymph node metastasis rate, local infiltration factor are independent related factors.